<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="9638" end="9643" sStart="9638" offset="0" sid="r7.1.use.v.0995" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="Using a cDNA fragment identical to the PAC-1 probe on the cDNA microarray, we performed a Northern blot analysis and confirmed the over-expression of two transcripts in leukemic LGL cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="12558" end="12562" sStart="null" offset="333" sid="r11.true.j.0863" wn="5" wnkey="true%5:00:00:typical:00" annotator="anfahmy" text="In order to accomplish the highest sensitivity and specificity in the presence of a complex background, Affymetrix introduced a system that entails the use of a series of specific and non-specific gene probe sets that are intended to result in a more accurate discrimination between true signal and random hybridization." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2105-3-22.anc" start="28296" end="28307" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" annotator="carichter" text="Then the proteins were &lt;b&gt;transferred&lt;/b&gt; to a membrane and Western blotting was performed using the monoclonal antibody for PAC-1 and A20, followed by the ECL technique as recommended by the manufacturer (Amersham Biosciences, Piscataway, NJ)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="18141" end="18146" sStart="null" offset="20" sid="r7.trace.v.0245" wn="2147483645" wnkey="null" annotator="veweser" text="In normal PBMC only trace amounts of both genes were identified, but after activation by PHA and IL2 only granzyme B was up-regulated." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="5870" end="5879" sStart="null" offset="58" sid="r8.suggest.v.0744" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="This is in contrast to the microarray data that suggested they were down regulated (Table 1)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="8956" end="8963" sStart="null" offset="28" sid="r8.suggest.v.0604" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="These observations strongly suggest that results for significantly altered genes should be confirmed with other traditional techniques such as Northern blots or RNase protection assays prior to reporting the fold increase." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="28459" end="28470" sStart="null" offset="196" sid="r11.recommend.v.0380" wn="1" wnkey="recommend%2:32:01::" annotator="anfahmy" text="Then the proteins were transferred to a membrane and Western blotting was performed using the monoclonal antibody for PAC-1 and A20, followed by the ECL technique as recommended by the manufacturer (Amersham Biosciences, Piscataway, NJ)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="25092" end="25098" sStart="null" offset="43" sid="r9.normal.j.0125" wn="3" wnkey="normal%3:00:03::" annotator="veweser" text="Briefly, total RNA isolated from normal PBMC and leukemic LGL were DNase-treated and purified with a Qiagen kit (Valencia, CA)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="13360" end="13366" sStart="null" offset="165" sid="r9.normal.j.0856" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="As a consequence, the strong MM signal masked the PM signal resulting in a low expression readout, even though the gene was present in normal PBMC (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="27204" end="27210" sStart="null" offset="72" sid="r9.normal.j.0684" wn="1" wnkey="normal%3:00:01::" annotator="brubin" text="RPAs were performed using the RNA isolated from leukemic LGL, normal PBMC and normal PBMC activated by IL-2 and PHA." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="6107" end="6111" sStart="null" offset="101" sid="r10.high.j.0684" wn="1" wnkey="high%3:00:02::" annotator="brubin" text="By microarray analysis, it is very difficult to distinguish between two genes that share a high degree of sequence similarity." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="veweser" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="9166" end="9170" sStart="null" offset="238" sid="r9.fold.v.0541" wn="2147483645" wnkey="null" annotator="veweser" text="These observations strongly suggest that results for significantly altered genes should be confirmed with other traditional techniques such as Northern blots or RNase protection assays prior to reporting the fold increase." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19076" end="19080" sStart="null" offset="273" sid="r9.fold.v.0113" wn="2147483645" wnkey="null" annotator="veweser" text="Previously, such systematic differences in the two technologies were reported [ 6 ] . For example, perforin showed a 103-fold change in the Affymetrix array, whereas the cDNA microarray showed only a balanced differential expression of 3.8-fold." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="sophiavv" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="cgozo" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="7500" end="7504" sStart="null" offset="15" sid="r9.fold.v.0795" wn="2147483645" wnkey="null" annotator="cgozo" text="Discrepancy in fold change calculation for a given gene" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="13432" end="13436" sStart="null" offset="49" sid="r9.fold.v.0551" wn="2147483645" wnkey="null" annotator="cgozo" text="Therefore, the subsequently calculated fold increase from the test sample was extraordinarily high and deemed unreliable." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="7932" end="7936" sStart="null" offset="141" sid="r9.fold.v.0231" wn="2147483645" wnkey="null" annotator="cgozo" text="This fact was clearly demonstrated by Kuo et al (2002) in their recent publication [ 6 ] . In this paper we compared the fold change (Affymetrix) and balanced differential expression (cDNA) with Northern blot expression." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="brubin" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="13027" end="13031" sStart="null" offset="86" sid="r9.fold.v.0340" wn="2147483645" wnkey="null" annotator="brubin" text="Unfortunately, the use of the mismatch probe information can interfere with fold change calculations of gene expression." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19294" end="19298" sStart="null" offset="49" sid="r9.fold.v.0292" wn="2147483645" wnkey="null" annotator="brubin" text="This problem may be due to an inaccurate fold change calculation due to the inclusion of mismatch values in the formula." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="9591" end="9595" sStart="null" offset="318" sid="r9.fold.v.0156" wn="2147483645" wnkey="null" annotator="brubin" text="One of the genes spotted on the cDNA microarray that we are interested in is ( Phosphatase in Activated Cells ) PAC-1 [ 9 ] . The differential expression of PAC-1 by both cDNA microarray (differential expression 4.2) and oligonucleotide arrays (fold change 1.6) is shown in Figures 3aand 3b." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="bpassonneau" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="19844" end="19848" sStart="null" offset="268" sid="null" wn="2147483645" wnkey="null" annotator="anfahmy" text="For example, genes for human autoantigen and human carboxyl ester lipase-like protein would be considered up-regulated in the microarray (according to PM match hybridization) if the MM hybridization values were ignored in the fold change calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="17983" end="17987" sStart="null" offset="90" sid="r11.able.j.0498" wn="1" wnkey="able%3:00:00::" annotator="adelpriore" text="However, using gene-specific probes in an RNase protection assay, we were able to distinctly identify the over-expression of both granzyme B and H in leukemic LGL cells (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2105-3-22.anc" start="7306" end="7310" sStart="null" offset="97" sid="r11.able.j.0276" wn="1" wnkey="able%3:00:00::" annotator="adelpriore" text="However, by using gene-specific probes in an RNase protection assay, we were able to demonstrate the over-expression of granzyme B and granzyme H separately in leukemic LGL cells (Fig." />
  </sentences>
</list>